Cerebrospinal Fluid Tau and β-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive Impairment
Open Access
- 1 November 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 59 (11) , 1729-1734
- https://doi.org/10.1001/archneur.59.11.1729
Abstract
Research from JAMA Neurology — Cerebrospinal Fluid Tau and β-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive ImpairmentKeywords
This publication has 11 references indexed in Scilit:
- Cerebrospinal fluid beta-amyloid and tau proteins for the diagnosis of Alzheimer disease.Archives of Neurology, 2001
- CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective StudyExperimental Neurology, 2000
- Frontotemporal lobar degenerationNeurology, 1998
- The Bayer Activities of Daily Living Scale (B-ADL)Dementia and Geriatric Cognitive Disorders, 1998
- Mechanism of Alzheimer neurofibrillary degeneration and the formation of tanglesMolecular Psychiatry, 1997
- A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairmentNeurology, 1996
- The Clinical Dementia Rating (CDR)Neurology, 1993
- Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes.Proceedings of the National Academy of Sciences, 1989
- The challenge of time: Clock‐drawing and cognitive function in the elderlyInternational Journal of Geriatric Psychiatry, 1986
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982